These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28572868)

  • 1. Prostate Cancer Patient Perspectives on the Use of Information in Treatment Decision-Making: A Systematic Review and Qualitative Meta-synthesis.
    Kandasamy S; Khalid AF; Majid U; Vanstone M
    Ont Health Technol Assess Ser; 2017; 17(7):1-32. PubMed ID: 28572868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolaris Cell Cycle Progression Test for Localized Prostate Cancer: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(6):1-75. PubMed ID: 28572867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
    Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
    JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.
    Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
    Eur Urol Oncol; 2018 May; 1(1):37-45. PubMed ID: 31100227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial.
    Thurtle D; Jenkins V; Freeman A; Pearson M; Recchia G; Tamer P; Leonard K; Pharoah P; Aning J; Madaan S; Goh C; Hilman S; McCracken S; Ilie PC; Lazarowicz H; Gnanapragasam V
    Eur Urol; 2021 Nov; 80(5):661-669. PubMed ID: 34493413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sources of Information for Learning and Decision-Making in Men With Localized Prostate Cancer.
    Chhatre S; Wittink MN; Gallo JJ; Jayadevappa R
    Am J Mens Health; 2020; 14(5):1557988320945461. PubMed ID: 33000703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
    O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
    Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
    Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
    BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative meta-synthesis examining the role of women in African American men's prostate cancer screening and treatment decision making.
    Bergner EM; Cornish EK; Horne K; Griffith DM
    Psychooncology; 2018 Mar; 27(3):781-790. PubMed ID: 29055290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
    Berry DL; Hong F; Blonquist TM; Halpenny B; Xiong N; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M
    Urol Oncol; 2021 Aug; 39(8):493.e9-493.e15. PubMed ID: 33353864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of health information-seeking behavior and personal factors on preferred role in treatment decision making in men with newly diagnosed prostate cancer.
    Davison BJ; Breckon EN
    Cancer Nurs; 2012; 35(6):411-8. PubMed ID: 22067700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision support for men with prostate cancer: Concordance between treatment choice and tumor risk.
    Filson CP; Hong F; Xiong N; Pozzar R; Halpenny B; Berry DL
    Cancer; 2021 Jan; 127(2):203-208. PubMed ID: 33119142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
    Rittenmeyer L; Huffman D; Alagna M; Moore E
    JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient reported factors influencing the decision-making process of men with localised prostate cancer when considering Active Surveillance-A systematic review and thematic synthesis.
    Cunningham M; Murphy M; Sweeney P; Richards HL
    Psychooncology; 2022 Mar; 31(3):388-404. PubMed ID: 34605104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decision analysis comparing 3 active surveillance protocols for the treatment of patients with low-risk prostate cancer.
    White C; Nimeh T; Gazelle GS; Weinstein MC; Loughlin KR
    Cancer; 2019 Mar; 125(6):952-962. PubMed ID: 30561761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When Primary Care Providers (PCPs) Help Patients Choose Prostate Cancer Treatment.
    Radhakrishnan A; Grande D; Ross M; Mitra N; Bekelman J; Stillson C; Pollack CE
    J Am Board Fam Med; 2017; 30(3):298-307. PubMed ID: 28484062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer.
    Lamers RE; Cuypers M; de Vries M; van de Poll-Franse LV; Ruud Bosch JL; Kil PJ
    Urol Oncol; 2017 Feb; 35(2):37.e9-37.e17. PubMed ID: 28341494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.